PROK Valuation

Prokidney Corp

Add to Watchlist

Advanced Chart

2.810

+0.11(4.074%)1D

PROK Relative Valuation

PROK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PROK is overvalued; if below, it's undervalued.

Historical Valuation

Prokidney Corp (PROK) is now in the Fair zone, suggesting that its current forward PS ratio of 2.70 is considered Fairly compared with the five-year average of -5.47. The fair price of Prokidney Corp (PROK) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：2.72

Fair

-5.11

Trailing

Forward

-8.91

EV/EBITDA

Prokidney Corp. (PROK) has a current EV/EBITDA of -8.91. The 5-year average EV/EBITDA is -6.59. The thresholds are as follows: Strongly Undervalued below -14.36, Undervalued between -14.36 and -10.47, Fairly Valued between -2.70 and -10.47, Overvalued between -2.70 and 1.19, and Strongly Overvalued above 1.19. The current Forward EV/EBITDA of -8.91 falls within the Historic Trend Line -Fairly Valued range.

-8.07

EV/EBIT

Prokidney Corp. (PROK) has a current EV/EBIT of -8.07. The 5-year average EV/EBIT is -6.28. The thresholds are as follows: Strongly Undervalued below -13.83, Undervalued between -13.83 and -10.06, Fairly Valued between -2.51 and -10.06, Overvalued between -2.51 and 1.26, and Strongly Overvalued above 1.26. The current Forward EV/EBIT of -8.07 falls within the Historic Trend Line -Fairly Valued range.

2.70

Prokidney Corp. (PROK) has a current PS of 2.70. The 5-year average PS is 137.29. The thresholds are as follows: Strongly Undervalued below -832.11, Undervalued between -832.11 and -347.41, Fairly Valued between 621.98 and -347.41, Overvalued between 621.98 and 1106.68, and Strongly Overvalued above 1106.68. The current Forward PS of 2.70 falls within the Historic Trend Line -Fairly Valued range.

-2.62

P/OCF

Prokidney Corp. (PROK) has a current P/OCF of -2.62. The 5-year average P/OCF is -2.73. The thresholds are as follows: Strongly Undervalued below -7.59, Undervalued between -7.59 and -5.16, Fairly Valued between -0.30 and -5.16, Overvalued between -0.30 and 2.13, and Strongly Overvalued above 2.13. The current Forward P/OCF of -2.62 falls within the Historic Trend Line -Fairly Valued range.

-2.25

P/FCF

Prokidney Corp. (PROK) has a current P/FCF of -2.25. The 5-year average P/FCF is -1.90. The thresholds are as follows: Strongly Undervalued below -5.15, Undervalued between -5.15 and -3.53, Fairly Valued between -0.27 and -3.53, Overvalued between -0.27 and 1.35, and Strongly Overvalued above 1.35. The current Forward P/FCF of -2.25 falls within the Historic Trend Line -Fairly Valued range.

Prokidney Corp (PROK) has a current Price-to-Book (P/B) ratio of -0.36. Compared to its 3-year average P/B ratio of -0.29 , the current P/B ratio is approximately 24.01% higher. Relative to its 5-year average P/B ratio of 42.78, the current P/B ratio is about -100.84% higher. Prokidney Corp (PROK) has a Forward Free Cash Flow (FCF) yield of approximately -0.36%. Compared to its 3-year average FCF yield of -63.02%, the current FCF yield is approximately -99.43% lower. Relative to its 5-year average FCF yield of -48.15% , the current FCF yield is about -99.26% lower.

-0.36

P/B

Median3y

-0.29

Median5y

42.78

-0.36

FCF Yield

Median3y

-63.02

Median5y

-48.15

Competitors Valuation Multiple

The average P/S ratio for PROK's competitors is 20.54, providing a benchmark for relative valuation. Prokidney Corp Corp (PROK) exhibits a P/S ratio of 2.70, which is -86.86% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Palvella Therapeutics Inc

Performance Decomposition

Market capitalization of PROK increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of PROK in the past 1 year is driven by Unknown.